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Abstract
We present a version of Chern et al.’s (1995) Bayesian model of
‘health risk belief’ to track the evolution of the ‘weight’ of epidemio-
logical evidence concerning tobacco harm that was in the possession
of the U.S. Tobacco Industry Research Committee (T.I.R.C.) and the
U.S. Public Health Service and related groups during the 1950s and
early 1960s. We compare our results with public statements assessing
the evidence that were made by the organisations during the same pe-
riod. The results from the models for the U.S. Public Health Service
and related groups are not in disagreement with the public statements
of these organisations; the results from the lung cancer model for the
T.I.R.C. are in disagreement with the assessments of the evidence made
by the T.I.R.C.’s Scientiﬁc Director in his annual reports. We discuss
possible reasons for this, relating our ﬁndings to present-day academic
and legal debates about the ‘controversy’ surrounding tobacco harm
during the mid-twentieth century.
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11 Introduction
Tobacco-related lawsuits worldwide have expended vast amounts of resources
arguing about the tobacco industry’s role in the ‘controversy’ surrounding
tobacco use and ill health during the mid-twentieth century. Central to these
debates has been the issue of when the ‘weight’ of scientiﬁc evidence indicting
tobacco became suﬃcient to declare its use harmful to health.
In this paper we present a version of Chern et al.’s (1995) Bayesian model
of ‘health risk belief’ to track the evolution of the ‘weight’ of epidemiologi-
cal evidence concerning the relationship between tobacco use and six cancer
sites that was in the possession of a number of American organisations dur-
ing the 1950s and early 1960s: the Tobacco Industry Research Committee
(T.I.R.C., renamed the Council for Tobacco Research-U.S.A., Inc., (C.T.R.)
in 1964), an industry body, and the U.S. Public Health Service and related
groups. Our sources come from a recent review of the epidemiological liter-
ature collected by these organisations (Forster et al. (2006)). To assess the
‘ﬁt’ of the models, we compare the results with public statements made by
the organisations during the same period. The results are also used to lend
insight into the manner in which the epidemiological evidence suggesting
that tobacco use is harmful accumulated during the early- to mid-twentieth
century.
We adopt a ‘qualitative’, Bayesian, perspective to the assimilation of
evidence, rather than the modern-day approach of cumulative meta-analysis.
We argue that our approach is better-suited to the way in which the T.I.R.C.
was evaluating the articles within its possession and can also be used to
represent elements of the way in which the U.S. Public Health Service and
related groups assessed the evidence. The paper complements recent work by
Parascandola et al. (2006) who present, for the U.S. Public Health Service,
a review of the manner in which two U.S. Surgeon General’s reports into
smoking and health applied causal criteria to the epidemiological evidence
that they reviewed. We ﬁnd that the results of our models for the U.S. Public
Health Service and related groups do not contradict their public assessments
of the evidence, but that the results of the models for the T.I.R.C. do not ﬁt
well the opinions expressed in the annual reports of its Scientiﬁc Director,
C.C. Little. We discuss possible reasons for this to be the case, including the
role of prior beliefs, the weight given by each organisation to epidemiological
evidence in an overall assessment of causality and the conﬂicting objectives
of the U.S. Public Health Service and related groups and the T.I.R.C..
The themes of this paper - an evolving evidence base suggesting harm,
conﬂicting expert opinion and the involvement of state and industry - are re-
ﬂected in other controversies, both contemporary and historical, surrounding
harm to human health and/or the environment (see, for example, the Eu-
ropean Environment Agency’s (2001) ‘Late Lessons from Early Warnings’).
In such instances, policy makers, industry and wider society must try to as-
2sess the state of evidence as it evolves over time and decide on what action,
if any, they should take. For a policy-maker, this might involve regulation
or prohibition; for the industry, changes in product speciﬁcation to reduce
risk; for the consumer, reducing consumption of, or ceasing to consume, the
product.
This paper is one of a series of three to result from our research, the
others being the review of the literature collected by the U.S. Public Health
Service and related groups and the T.I.R.C., which provides the data for the
inputs to the models in this paper (Forster et al., 2006), and a review of the
inner-workings of the T.I.R.C. between 1954 and 1964, especially the role of
the academics who served on its Scientiﬁc Advisory Board (Bowden et al.,
2006).
The rest of this paper is organised as follows. In section 2 we discuss the
historical, legal and academic background to the work before outlining the
model (section 3), presenting results (section 4) and discussing them (section
5). Section 6 concludes.
2 Background
The invention of the ‘Bonsack’ machine in the 1880s allowed
cigarettes to be produced at a fraction of the unit cost prevailing at the
time, heralding an era in which the smoking habit became accessible to the
whole of society rather than just those in elite circles (Hilton, 2000).1 By
1955 in the U.S.A., around 65% of men and 35% of women were thought to
be regular cigarette smokers (Haenszel et al., 1956).
It was concern with the increasing incidence of cancer, especially of the
lung and bronchus, during the ﬁrst half of the twentieth century, which led
researchers to investigate whether tobacco use played a causal role. Retro-
spective epidemiological studies can be traced back to the early 1920s and
large prospective studies to the 1950s.
The 1950s was the decade during which the evidence suggesting that
cigarette smoking caused lung cancer started to cause serious concern within
society. That decade was also the one in which the tobacco companies, ware-
house and growers’ associations formed the T.I.R.C. and the U.S. Public
Health Service and related groups started to issue their ﬁrst public state-
ments assessing the evidence concerning smoking and lung cancer. During
this decade and the next, much scientiﬁc argument took place about whether
or not tobacco played a causal role in cancer, cardiovascular disease and
other respiratory diseases, argument which has been revisited in the tobacco
litigation cases and academic literature of today.2
1Parts of this section are based on the historical notes in Forster et al. (2006).
2More details of the historical context may be found in many sources, including Talley
et al. (2004), Parascandola (2004) and Doll (1998).
32.1 Contemporary legal and academic perspectives
Recent legal judgments in tobacco-related lawsuits in the U.S.A., the United
Kingdom and the Republic of Ireland have expressed markedly diﬀering opin-
ions on dating the end of the ‘controversy’ surrounding whether or not to-
bacco is harmful to health. Their verdicts and orders have been equally var-
ied. The 2006 Racketeer Inﬂuenced and Corrupt Organizations (R.I.C.O.)
judgment (United States of America v. Philip Morris U.S.A., Inc., et al.,
2006) concluded that the ‘overwhelming medical and scientiﬁc consensus’
that smoking cigarettes causes disease had been established by the early
1950s [page 3] and that the tobacco companies had been involved in ‘a mas-
sive 50-year scheme to defraud the public’ [page ES-1]. It judged the United
States to be entitled to ‘at least’ $280bn of ‘disgorgement of proceeds’ [page
ES-26]. Also in 2006, the Court of Appeal of the State of California cited
the late 1950s as being the time by which there existed general agreement
that smoking caused lung cancer within the scientiﬁc and medical profession
‘after several epidemiological studies reached that conclusion’ [page 3]. It af-
ﬁrmed an award of $28m in punitive damages against Philip Morris U.S.A.,
Inc., for its ‘extremely reprehensible’ conduct in perpetuating a ‘false con-
troversy’ regarding tobacco’s harmful eﬀects during the 1950s and beyond
(pages 2, 15, 65, Jodie Bullock v. Philip Morris, U.S.A., Inc., 2006).3
However, judgments on the other side of the Atlantic have reached
markedly diﬀerent conclusions. In 2005, in the Scottish Court of Session,
Lord Nimmo Smith judged that, by 1964, the general public in the United
Kingdom were ‘well aware’ of the view that smoking could cause lung cancer
[par. 9.4]. However, the defendant, Imperial Tobacco Limited, averred that
‘[c]igarette smoking has not been scientiﬁcally established as a cause of lung
cancer’ and that ‘the cause or causes of lung cancer are unknown and the
mechanism or mechanisms whereby lung cancer develops are unknown’ [par.
2.7]. Lord Nimmo Smith judged it was not within ‘judicial knowledge’ that
smoking caused lung cancer [par. 9.7] and that the plaintiﬀ, a victim of lung
cancer, had failed to prove that his lung cancer was probably caused by his
smoking [par. 6.185]. Nimmo Smith dismissed the plaintiﬀ’s claim for dam-
ages (McTear v. Imperial Tobacco Ltd., 2005). In 2004 in the High Court of
Ireland, Justice F. Geoghegan dismissed claims of alleged negligence by three
plaintiﬀs against three tobacco companies without assessing any evidence.
In part of his judgment he commented:
‘the claims would require the court to decide issues of fact per-
taining to the state of scientiﬁc knowledge [regarding tobacco
harm] which they either were aware of or ought to have been
3Opinion is presently noted as being ‘superseded’. A petition for review brief-
ing is deferred pending a decision on the level of punitive damages to be awarded
in Philip Morris U.S.A. v. Williams or further order of the court. See
www.courtinfo.ca.gov/opinions/archive/B164398.PDF
4aware of and the precise decision taken by the defendants not
only in relation to the manufacturing but including detailed de-
cisions eﬀecting such matters as the level of nicotine over much of
the twentieth century ...For a court to be asked in the years 2006
or 2008 or later to determine issues of fact of the nature which
would be required by these claims...“puts justice to the hazard”’
(Section entitled ‘Dismiss in the interests of justice’, Manning v.
Benson and Hedges Ltd., 2004).
Such debates are not limited to courts of law; the subject has also ex-
ercised many in the academic world. Talley et al. (2004) argue that ‘there
was a legitimate and reasonable scientiﬁc controversy over cigarette smoking
and lung cancer in the 1950s and early 1960s’ [page 329]. They describe
Stolley’s (1991), Kluger’s (1997) and Glantz et al.’s (1996) accounts of the
scientiﬁc controversy in the mid-20th century as being ‘ahistorical’ in not
having adopted an appropriate historical perspective. Parascandola (2004)
writes about the roles of statisticians R. A. Fisher and J. Berkson, both of
whom, he notes, have been accused of ‘taking the ‘wrong’ side of the debate’
in the controversy. He argues that Fisher’s and Berkson’s support for the
controlled experiment, the ‘crucial, objective test of a causal hypothesis’,
was in conﬂict with the views of those who argued for an ‘inferential judg-
ment based on a diverse body of evidence.’ Parascandola cites the Surgeon
General’s 1964 report as being the ‘authoritative statement of the proper
method for assessing a body of etiological evidence.’ Such legal and aca-
demic debate is not helped by the potential conﬂicts of interest thrown up
by tobacco industry funding of scientists and academics as consultants and
expert witnesses both today and during the 1950s and 1960s.4
4In a declaration fronting Talley et al. (2004) it is stated that two of the authors (Talley
and Kushner) have consulted with a tobacco industry law ﬁrm specialising in ‘recruiting
and developing expert witnesses for the defense in tobacco industry lawsuits.’ Kushner is
described as having ceased ties with the ﬁrm and it is explained that neither author plans
to work on tobacco-related litigation in the future. To support their argument about the
legitimacy of the ‘controversy’ prior to 1964, Talley et al. cite the views of Paul M. Kotin
[pages 349, 351, 354], who served as a member of the Scientiﬁc Advisory Board of the
T.I.R.C., between 1954 and 1965 (when he resigned). This membership is not stated in
Talley et al.’s paper. Talley et al. and Parascandola also cite the views of Berkson who,
according to the recent R.I.C.O. judgment (pages 64, 286, United States of America v.
Philip Morris U.S.A., Inc., et al., 2006), at the time of publication of the Surgeon General’s
1964 report ‘Smoking and Health’, was receiving consultancy fees of $8,000 per annum
from ‘Special Account No. 3’ operated by Philip Morris, R.J. Reynolds, Lorillard, Liggett,
Brown and Williamson and American Tobacco. According to the R.I.C.O. judgment,
Special Account No. 3 was created by the tobacco companies to be a tobacco lawyers’
‘work product’ and thus not subject to subpoena (page 203, United States of America
v. Philip Morris U.S.A., Inc., et al., 2006). It is not clear to us when this information
regarding Berkson’s consultancy became public. Neither Talley et al. nor Parascandola
make reference to it. Berkson’s arguments formed part of the defence case for Imperial
Tobacco Ltd. in McTear v. Imperial Tobacco Ltd. (2005).
52.2 Roles of the T.I.R.C. and the U.S. Public Health Service
and related groups
The Tobacco Industry Research Committee
The T.I.R.C. was founded at the end of 1953 by the majority of the U.S.
tobacco companies, growers and warehouse associations. It aimed to ‘aid and
assist research into tobacco use and health, and particularly into the alleged
relationship between tobacco use and lung cancer, and to make available to
the public factual information on this subject’ (page 3, C.T.R., not dated).
In an attempt to split the research and public relations aspects of its work, a
‘Scientiﬁc Advisory Board’ was created and charged with promoting and
funding scientiﬁc research. Also formed were a Law Committee and an
Industry Technical Committee, which comprised the research directors of
the member companies (pages 3, 5, C.T.R., not dated). The T.I.R.C. also
operated a library to collect together papers investigating the relationship
between tobacco and health, which served the Committee itself, its scientiﬁc
staﬀ, the S.A.B. and the tobacco industry. The library did not serve the
general public (pages 7-8, C.T.R., not dated).
Documents from the T.I.R.C. archives have been made publicly available
courtesy of what is known as the ‘Master Settlement Agreement’ of 1998, an
agreement signed by the Attorneys General of 46 U.S. states and the four
largest U.S. tobacco companies (National Association of Attorneys General,
1998). The agreement introduced major restrictions on the advertising, mar-
keting and promotion of cigarettes, dissolved the C.T.R. and required the
tobacco companies to open, at their own expense, websites holding all ‘non-
privileged’ documents requested in relevant state and other smoking-related
lawsuits (non-privileged documents being those documents for which the
tobacco companies did not make a claim of attorney-client privilege, trade-
secret protection and so on). These documents are collected together in a
number of websites, including the Legacy Tobacco Documents Library at the
University of California, San Francisco5 and ‘tobaccodocuments.org’.6
As described in detail in Forster et al. (2006), two conﬁdential publi-
cations produced by the T.I.R.C.’s library which summarise literature on
tobacco and health are used to provide the data for the T.I.R.C. models pre-
sented in this paper. One is entitled ‘A working reference catalog’ (hereafter
‘the Catalog’), a T.I.R.C. listing of scientiﬁc literature on tobacco and health
published prior to 1st August 1955. The other is entitled ‘Current Digest
of Scientiﬁc Papers Relating to Tobacco Use’ (hereafter ‘Current Digest’),
a monthly publication ﬁrst published in July 1956, which summarised the
tobacco-health literature as it was published.7
5http://legacy.library.ucsf.edu/
6http://tobaccodocuments.org/
7A copy of the catalog may be obtained from
http://tobaccodocuments.org/ness/5305.html or
6The Catalog was compiled by the T.I.R.C.’s ﬁrst librarian, Kenneth
Austin. Austin obtained relevant scientiﬁc articles published prior to 1st
August 1955 and classiﬁed them by author under a range of headings relat-
ing to the smoking/health question. Austin assigned a code letter A to E
to each article that he summarised. ‘A’ meant that the paper took a ‘favor-
able’, ‘B’ a ‘neutral or unrelated’ and ‘C’ an ‘unfavorable’ position on the
eﬀects of tobacco (T.I.R.C., not dated (b)). ‘D’ denoted that ‘[n]either paper
nor excerpt is on ﬁle, but copies ...can be obtained from medical libraries
or publishers’ and ‘E’ denoted ‘[c]opies of full paper on ﬁle but no excerpt
or abstract available.’ In a trial deposition from 1986, Austin’s successor,
William D. Jenkins, explains that he interpreted the letters A to C as fol-
lows: ‘A’ means ‘not harmful ...tobacco is not harmful’; ‘B’ means ‘neutral’
and ‘C’ means ‘tobacco is harmful’ (page 42, deposition of W. D. Jenkins,
Almquist et al. v. American Brands, Inc., et al., 1986).
To identify literature reviewed by the T.I.R.C. after 1st August 1955, we
used the Current Digest. Austin scanned the scientiﬁc publications to which
the T.I.R.C. subscribed, together with abstracts of the world literature and,
together with his staﬀ, checked the scientiﬁc publications at the New York
Academy of Medicine. ‘Pertinent’ articles were then selected and used to
compile the Current Digest. By 1968 it was claimed that the library received
129 scientiﬁc publications, ten publications abstracting the literature, and
information on monitoring of 2,500 U.S. and foreign journals carried out by
the Philadelphia College of Physicians (Austin, 1968).
Forster et al. (2006), in reviewing the quality of the T.I.R.C.’s litera-
ture retrieval and review process, found it to be unbiased and reasonably
comprehensive. From 1956 onwards, it was providing summaries of pub-
lished epidemiological studies to T.I.R.C. members within an average of 2.3
months of date of publication. It is the simple categorical classiﬁcations of
the studies within the T.I.R.C.’s possession (tobacco harmful, not harmful,
neutral) that are reported in Forster et al. (2006) that are used as inputs to
the T.I.R.C. model presented in this paper.
Our sources for the T.I.R.C.’s public statements assessing the evidence
are the annual reports of its Scientiﬁc Director, C.C. Little. Each report
contains a general assessment of the evidence concerning tobacco harm and
then presents detailed information on the research program and projects
funded by the T.I.R.C.. In these reports, we focus on Little’s statements
concerning the role of epidemiological evidence in making judgments about
causality and whether or not he believed tobacco use to be causally related
to the cancer sites considered in this paper.
http://legacy.library.ucsf.edu/tid/ejx71e00. Copies of the Current Digest
may be downloaded from the Legacy Tobacco Documents Library site.
7The reports of the U.S. Public Health Service and related groups
The United States Public Health Service and related groups published a
number of reviews of the literature and statements on smoking and lung
cancer during the 1950s and a major report on tobacco use and health by
an advisory committee to the U.S. Surgeon General in 1964.
In 1957, a scientiﬁc study group examined 18 independent epidemiologi-
cal studies into the smoking/lung cancer question, together with experimen-
tal and pathological evidence, and concluded that ‘[t]he sum total of scien-
tiﬁc evidence establishes beyond reasonable doubt that cigarette smoking is
a causative factor in the rapidly increasing incidence of human epidermoid
cancer of the lung’ (page 1129, Study Group on Smoking and Health, 1957).
Around the same time, Surgeon General Burney stated that the U.S. Public
Health Service ‘feels that the weight of evidence is increasingly pointing in
one direction: that excessive smoking is one of the causative factors in lung
cancer’ (page 44, Burney, 1958).
In 1959, reviewing additional evidence, including newly-published epi-
demiological studies, Burney stated that ‘the weight of evidence at present
implicates smoking as the principal factor in the increased incidence of
lung cancer ...cigarette smoking particularly is associated with an increased
chance of developing lung cancer’ (pages 1835-6, Burney, 1959).
The Surgeon General’s ‘Advisory Committee on Smoking and Health’ was
an expert committee formed in 1962 and charged with making ‘an objective
assessment of the nature and magnitude of the health hazard [associated
with tobacco use].’ Its job was to review critically all available data but
not to conduct new research. The Committee set out to investigate whether
or not the use of tobacco was bad, good or devoid of eﬀects on health and
considered the question from the perspective of overall mortality as well as
disease categories.
The Advisory Committee combined epidemiological evidence with that
from experimental, clinical and pathological studies in an attempt to make
judgments on causality for six cancer sites, cardiovascular disease and other
diseases thought to be related to smoking. The Committee was clear about
the value of epidemiological evidence, which was ‘used extensively in the
assessment of causal factors in the relationship of smoking to health among
human beings upon whom direct experimentation could not be imposed.’
It is the prospective and retrospective epidemiological studies which form
the focus of this paper, that were described by the Committee as having
furnished information ‘of the greatest value.’
In contrast to the T.I.R.C., the Advisory Committee laid out explicit
criteria for assessing the evidence within its possession. Further, it was clear
about its view of the role of statistical associations in assessing causality:
‘[s]tatistical methods cannot establish proof of a causal relationship in an as-
sociation. The causal signiﬁcance of an association is a matter of judgment
8U.S. Public Health Service and related groups
• 1957: Study Group on Smoking and Health (1957); Surgeon Gen-
eral Burney’s statement of 1957 (Burney, 1958)
• 1959: Surgeon General Burney’s statement of 1959 (Burney, 1959)
• 1964: U.S. Surgeon General’s Advisory Committee on Smoking
and Health (U.S. Department of Health, Education and Welfare,
Public Health Service, 1964)
Tobacco Industry Research Committee
• Pre-August 1955: the Catalog
• Post-July 1956: the Current Digest
Figure 1: Sources of data for Bayesian models solved in this paper.
which goes beyond any statement of statistical probability’ [page 20]. The
ﬁrst stage in assessing the evidence is described by the Advisory Committee
as establishing whether an association is observed between host and agent
[page 20]. The second stage is assessing whether identiﬁed associations are
causal [page 21]. Causality is taken to mean ‘a signiﬁcant, eﬀectual, relation-
ship between an agent and an associated disorder or disease in the host’ [page
21]. The criteria for assessing causality included the consistency, strength
and speciﬁcity of associations, as well as their temporal relationship and co-
herence (whether the results agree with the natural history and biology of
the disease). These are described in more detail in the report itself, as well
as in Forster et al. (2006) and Parascandola et al. (2006).
The Advisory Committee’s report - ‘Smoking and Health’ - was published
on January 11th, 1964. Finding cigarette smoking associated with a seventy
per cent increase in the age-speciﬁc death rates of males and an increased
death rate of females, it concluded that cigarette smoking ‘contributes sub-
stantially to mortality from certain speciﬁc diseases and to the overall death
rate’ and that it ‘is a health hazard of suﬃcient importance in the United
States to warrant appropriate remedial action’ [page 31]. Regarding the re-
lationship between smoking and lung cancer, it concluded that ‘[c]igarette
smoking is causally related to lung cancer in men; the magnitude of the eﬀect
of cigarette smoking far outweighs all other factors. The data for women,
though less extensive, point in the same direction’ [page 31-3].
A summary of the organisations and sources whose data form the inputs
to our Bayesian model is shown in ﬁgure 1.
93 Application of Chern et al.’s model
Chern et al. (1995) model how a ‘representative consumer’s’ beliefs regarding
the health risk associated with saturated fat consumption evolved as the
evidence base concerning the potential of saturated fats to harm human
health changed between 1966 and 1987. The inputs to their model are the
data from Brown and Schrader’s (1990) ‘cholesterol index’, constructed from
a review of medical journal publications which deal with the ‘human and
clinical implications’ of cholesterol and which, in the opinion of Brown and
Schrader, are most likely to have been read by U.S. physicians.8 935 articles
are included in the series and classiﬁed by the authors as either supporting
or attacking the hypothesised link between cholesterol and heart disease.
In the models presented in this paper, we consider the beliefs of a decision-
maker who reviews a sequence of articles published in primary sources and
which report the results of epidemiological studies (both prospective and ret-
rospective) investigating the links between tobacco use and cancer at one of
six sites: the lung, oral cavity, larynx, oesophagus, urinary bladder and stom-
ach. Each epidemiological study reviewed is classiﬁed by the decision-maker
according to whether or not it suggests that tobacco use causes cancer at the
site of interest. The decision-maker’s beliefs concern the population propor-
tion of such studies that would conclude that tobacco use causes cancer at
the site, were it possible to observe all of the studies in the population. Prior
to observing any studies, the decision-maker believes that tobacco use is not
harmful to the site and therefore expects that few studies in the population
will conclude that it is. As time passes, the decision-maker reviews newly-
published articles and classiﬁes each according to whether it suggests that
tobacco use is harmful, beneﬁcial, or neutral, or whether the study results
are inconclusive or unclear. Beliefs are updated using this new information
and, from time to time, are combined with evidence from other sources (such
as the results of experimental work, chemical and pharmacological analyses
of tobacco and its eﬀects), in an assessment of whether or not the evidence
is strong enough to declare publicly that the relationship between tobacco
use and cancer of the site in question is causal.
3.1 The model
Consider the population of all epidemiological studies investigating the re-
lationship between tobacco use and cancer in one of the six sites. Let
p ∈ [0,1] be the population proportion of studies that conclude that tobacco
use is harmful. Let Pt ∈ [0,1] be a Beta random variable (Pt ∼ Be(at,bt),
at,bt ∈ R+) deﬁned at each point t ∈ T of the time horizon, where T is
the set {t0,t1,...,T} and T < ∞. t0 is a point in time prior to the date of
8The authors consider only articles written in English and exclude ‘all Scandanavian,
British and Canadian articles’.
10publication of the ﬁrst epidemiological study reviewed by the decision-maker
and T is the ﬁnal point in the time horizon (in our model the ts represent
years and t0 = 1919 and T = 1963; 1920 was the year in which the ﬁrst
case-control study for our series (looking at oral cancer (Broders, 1920)) was
published).
Prior beliefs are deﬁned by choosing suitable values for at0 and bt0, yield-
ing the following density f for Pt0:
f(Pt0) ∝ pat0−1(1 − p)bt0−1. (1)
For each t ∈ T, the decision-maker observes a total of nt ∈ Z+ new studies
meeting its inclusion criteria, of which xt ∈ {0,...,nt} are classiﬁed by the
decision-maker as suggesting that tobacco use is harmful.
The decision-maker, in classifying a study, can take into account the re-
sults of ‘classical’ statistical hypothesis tests carried out as part of the study,
together with other factors such as an assessment of the overall quality of
the study’s design, the competence of the study’s investigators, the conclu-
sions drawn by the investigators, and so on. Assuming a prior position that
tobacco is not harmful, the decision-maker knows that, even if it is truly the
case that tobacco is not harmful, some studies might incorrectly conclude
that it is, perhaps because a hypothesis test in the study has made a Type I
error. The decision-maker is therefore aware that, in the population of stud-
ies, it would be possible to observe a low proportion of studies concluding
that tobacco use is harmful, even if it is not. However, the decision-maker
is also aware that it is possible that tobacco use is harmful, in which case
the decision-maker would expect to observe a higher proportion of studies
classiﬁed as ‘tobacco harmful’ in the population. To reﬂect these beliefs,
the prior for p will be centered around a low, but non-zero, value (implying
that E[Pt0] is low) but will assign a non-zero probability to p taking higher
values. The strength of the decision-maker’s prior beliefs will be reﬂected in
var(Pt0). Appendix A provides a more detailed interpretation of the ‘mean-
ing of ‘p” under the two scenarios ‘tobacco not harmful/neutral’ and ‘tobacco
harmful.’
In year t1, the decision-maker observes a sample of nt1 studies from the
population, of which xt1 are classiﬁed as suggesting that tobacco use is harm-
ful.9 Assuming that the sample consists of random and independent draws
from the population, the probability of classifying xt1 studies as ‘tobacco
harmful’, from a total of nt1 new studies, is of the form:
g(xt1|P) ∝ pxt1(1 − p)nt1−xt1. (2)
Bayes’ theorem for the posterior distribution of beliefs is:
f(Pt1|xt1) ∝ g(xt1|p)f(Pt0), (3)





t = t + 1
at = at−1 + xt
Prior beliefs (at0,bt0)





Observe xt from nt
studies rejecting H0
Figure 2: Updating process for beliefs.
implying, using (1) and (2), that posterior beliefs are such that:
f(Pt1|xt1) ∝ pat0+xt1−1(1 − p)bt0+(nt1−xt1)−1.
Hence, at the posterior stage, Pt1 ∼ Be(at0 + xt1,bt0 + (nt1 − xt1)).
The process of updating beliefs can be represented using a simple set of
diﬀerence equations and is shown in Figure 2. Given starting values for at0
and bt0, at and bt will evolve according to:
at = at−1 + xt, (4)
bt = bt−1 + (nt − xt), (5)






where Γ is the gamma function. Expressions for the mean and variance of







(at + bt)2(at + bt + 1)
. (7)
The idea is that, when a causal relationship does exist between tobacco use
and cancer of a particular site, there arrives a point at which the ‘weight
of evidence’ (reﬂected in E[Pt]), combined with a particular degree of cer-
tainty (reﬂected in var(Pt)) and other corroborative evidence, ‘persuades’
12the decision-maker to declare the relationship between tobacco use and the
cancer ‘causal’.
The major diﬀerences between Chern et al.’s model and ours is that,
ﬁrstly, Brown and Schrader’s ‘cholesterol index’ does not appear to have lim-
ited its inclusion criteria to epidemiological studies.10 Secondly, Chern et al.
interpret their model’s outputs to be beliefs concerning diet and disease re-
lationships held by the population whereas, in our model, a decision-maker’s
beliefs are limited to the population proportion of epidemiological studies
concluding that tobacco use is harmful.
For the rest of this section we describe the model for one cancer site. The
methods described are applied to all sites in models for: (a) the T.I.R.C. and
(b) the U.S. Public Health Service and related groups.
3.2 Prior beliefs
From reading the history of the tobacco story, it is clear that there was
initial resistance in the medical, scientiﬁc and wider community, to the idea
that tobacco use could harm human health. We account for this in setting
prior beliefs to reﬂect the decision-maker’s beliefs that few studies in the
population conclude that tobacco use is harmful. To reﬂect the fact that the
epidemiological studies reviewed all apply ‘classical’ statistical hypothesis
tests, we choose E[Pt0] = 0.0375, reﬂecting the proportion of studies one
would expect incorrectly to conclude that tobacco is harmful if the average
probability of making a Type I error within the population of all studies
equals 3.75%. E[Pt0] = 0.0375 implies, from (6), that at0 = 3bt0/77. We
choose bt0 = 38, implying that at0 = 114/77 and the distribution for Pt0
is such that there is a probability of 0.95 that p lies within the interval
[0.003,0.11]. Appendix A discusses this choice of prior beliefs in more detail.
3.3 Updating of beliefs
The sources of data used to update beliefs are taken from tables 2 to 9 of
Forster et al. (2006). These list the major prospective and retrospective
studies investigating the relationship between tobacco use and the six cancer
sites considered in this paper and identiﬁed by Forster et al. as having been
reviewed by the T.I.R.C. and/or the U.S. Public Health Service and related
groups during the 1950s and early 1960s.11
Starting with the prior values for at0 and bt0, for each organisation and
for all t ∈ T, xt and nt were calculated from the tables and substituted into
(4) and (5), which were, in turn, used to calculate the mean and variance of
10The index appears to comprise all articles dealing with the ‘human and clinical im-
plications’ of cholesterol with regard to heart disease or arteriosclerosis.
11Full details on how the tables were compiled may be found in Forster et al. (2006).
13Pt using (6) and (7).12 Two sets of results are presented for the six cancer
sites. The ﬁrst set deals exclusively with the studies reviewed in the U.S.
Surgeon General’s Advisory Committee’s report of 1964. For each of the six
cancer sites, we plot the evolution of the mean and variance of P according
to the year in which the studies reviewed by the Advisory Committee were
published. nt therefore represents the total number of studies published
in year t and xt the number which the Advisory Committee classiﬁed as
‘tobacco use harmful’ in its 1964 report. In this section, the outputs of
the model show how the Committee’s beliefs would have evolved had it
assessed the evidence considered in ‘Smoking and Health’ as that evidence
emerged. For each cancer site, we compare the values E[P1963] and var(P1963)
with the Advisory Committee’s evaluation of the evidence presented in its
report. This set of results aims to show, ﬁrstly, in graphical format, how the
epidemiological evidence evolved over time for each of the six cancer sites.
Secondly, it is used to consider how ‘well’ the model performs, in terms of
the degree to which the assessments of the evidence made by the Advisory
Committee in 1964 match the results of the model.
In the second set of results, we consider the perspectives of the U.S. Public
Health Service and related groups and the T.I.R.C. between 1950 and 1963.
The T.I.R.C. series are plotted according to the dates at which we know
the evidence was reviewed by the T.I.R.C. (in either the Catalog (1955) or
the Current Digest (yearly from 1956 onwards)). We also consider how the
T.I.R.C. interpreted the evidence for lung cancer in the annual reports of its
Scientiﬁc Director. For the U.S. Public Health Service and related groups,
the series are plotted according to the dates at which the service reviewed
the evidence and released public statements evaluating it. This corresponds
to the years 1957 (report of the Study Group on Smoking and Health and
statement of the Surgeon General), 1959 (second statement of the Surgeon
General) and 1964 (year of publication of ‘Smoking and Health’). The focus
in the second set of results is therefore on the timing of reviews of the evidence
by the T.I.R.C. and the Public Health Service and related groups and the
degree to which outputs of the models for the six cancer sites match the
public statements of the organisations over time.
Before turning to the results, we note that we are not directly modelling
the Bayesian approach to assessing the probability that the null hypothesis
12For the T.I.R.C. series for the years prior to 1956, xt is given by the total number
of ‘C’ (tobacco harmful) classiﬁcations in Forster et al.’s tables. For the T.I.R.C. series
for 1956 and beyond, xt is the total number of ‘Y’ classiﬁcations recorded in the tables.
Studies noted in Forster et al.’s tables as not being clear retrospective studies in the
Current Digest summary were excluded from the series. The classiﬁcations of the studies
in the possession of the U.S. Public Health Service and related groups were taken from its
public statements of 1957 and 1959 (lung cancer only) and Forster et al.’s tables relating
to the Advisory Committee’s report of 1964. In rare cases where a study was interpreted
as being ‘unclear’ in its conclusions (a ‘B’ (Catalog) or ‘U’ (all other sources) in Forster
et al.’s tables), we classiﬁed it as ‘tobacco not harmful’.
14is true given a set of data (i.e. P(H0 true | data)). Rather, the estimation
concerns the population parameter p which, in turn, forms part of a wider
body of evidence used by the decision-maker to assess the relationship be-
tween tobacco use and cancer. There will be no ‘threshold’ level of p beyond
which a relationship is automatically declared as being ‘causal’. Further, as
discussed in the appendix, when tobacco is harmful, the population value
of p depends on, amongst other factors, the distribution of the power of the
hypothesis tests within the population of studies to detect a true diﬀerence.
This is, in turn, determined by factors such as the sample size of the studies
and the degree to which the disease is multi-causal in nature (other things
being equal, the more the presence of a disease can be ‘explained’ by to-
bacco use, the greater will be the power of hypothesis tests to detect a true
diﬀerence).
4 Results
4.1 Results for the Surgeon General’s Advisory Committee’s
report of 1964
In this section of the paper, our models use as inputs the year of publication
of the articles reviewed by the Surgeon General’s Advisory Committee that
are listed in Tables 2 to 9 of Forster et al. (2006). Table 1 compares, for
the Surgeon General’s Advisory Committee, the mean and variance of the
distribution of beliefs regarding p in 1963 to those of prior beliefs (in 1919).
Plots of how the mean and variance of p evolve over time for each cancer site,
together with details of the Committee’s evaluation of the evidence within
its possession in 1963, are presented in Figures 3 to 5. To aid comparability,
we plot each series against a common time line, using 1919 as the starting
point.
Table 1 shows that E[P1963] is higher than E[P1919] for all cancer sites
except stomach cancer, reﬂecting the increase in the ‘weight’ of epidemiolog-
ical evidence linking tobacco use to cancer for these sites during the period
in question. Viewed in terms of the expected values, the table shows the
weight of evidence to be strongest for lung cancer, followed by cancer of the
oral cavity,13 laryngeal cancer, oesophageal cancer and cancer of the urinary
bladder. The variance is higher in 1963 than in 1919 for all ﬁve of these
13For oral cancer, the Surgeon General’s Advisory Committee broke down the results
of studies to consider cancer at speciﬁc sites of the oral cavity and its relation to speciﬁc
forms of tobacco use (pipe smoking, chewing and so on). For our model, we considered
a study’s results to support a causal link between tobacco use and oral cancer as long as
the Advisory Committee classiﬁed the study as suggesting that tobacco use caused cancer
at least one site within the oral cavity. For some studies, although such a classiﬁcation
was made for one site in the oral cavity, links between tobacco use and cancer at other
sites in the oral cavity were either classiﬁed by the Advisory Committee as associations
‘of doubtful signiﬁcance’ or ‘absent or not signiﬁcant’.
15Cancer site E[Pt] var(Pt) Overall assessment
Starting values for all sites (t = 1919) 0.0375 0.0009
Values of series (t = 1963)
Lung 0.4966 0.0033 Causal
Oral cavity 0.3272 0.0038 Causal (lip only)
Larynx 0.1916 0.0031 Causal
Oesophagus 0.1429 0.0026 Association
Urinary bladder 0.1260 0.0025 Association
Stomach 0.0340 0.0007 No relationship
Table 1: Surgeon General’s Advisory Committee: means (E[Pt]) and vari-
ances (var(Pt)) for the distribution of beliefs for each cancer site in 1919
(prior) and 1963, together with the Committee’s judgment as to the nature
of the relationship between tobacco use and cancer at each site.
cancer sites, reﬂecting the fact that prior beliefs about p have been contra-
dicted by the sample evidence. For stomach cancer, E[Pt] and var(Pt) vary
little between 1919 and 1963, reﬂecting the fact that none of the four stud-
ies reviewed by the Advisory Committee were classiﬁed as suggesting that
a causal link existed between tobacco use and stomach cancer; the sample
evidence supports prior beliefs and hence mean and variance change little.
Comparing the way the model ranks the six sites to the overall assessment
regarding the relationship between tobacco use and cancer at each site as
made by the Advisory Committee, table 1 shows a reasonable match. The
Committee declared that a ‘causal’ relationship existed for three of the sites
(lung, oral cavity (lip only) and larynx), that associations existed for two of
them (oesophagus and urinary bladder) and that no relationship had been
established between tobacco use and stomach cancer. The model’s ranking
in table 1 ﬁts these assessments.
Consider now how the series evolve over time. Figure 3 shows that, for
both lung and oral cancer, E[Pt] is non-decreasing throughout the period in
question. This reﬂects the fact that, for both sites, every study reviewed by
the Surgeon General’s Advisory Committee was classiﬁed as ‘tobacco harm-
ful’. For oral cancer, the ﬁrst change in the mean and variance occurs in
1920, with the publication of Broders (1920). Thereafter, sporadic publica-
tion of studies increases the mean during the rest of the 1920s, 1930s and
1940s, before more frequent publication of studies is observed during the
1950s. As the total number of studies classiﬁed as ‘tobacco harmful’ in-
creases, the marginal impact of a study concluding that tobacco is harmful
on E[Pt] is strictly positive but strictly decreasing.14 This can be observed
by comparing the increment in the mean between years when one additional




































Lung cancer: Bayes var*100  Oral cancer: Bayes var*100 
Figure 3: Lung and oral cancer series for Surgeon General’s Advisory Com-
mittee: mean and 100*variance of distribution of beliefs regarding p, 1919 -
1963.
Advisory Committee’s assessment of the evidence for each site:
Lung cancer - ‘Cigarette smoking is causally related to lung cancer in men; the
magnitude of the eﬀect of cigarette smoking far outweighs all other factors. The
data for women, though less extensive, point in the same direction.’
Cancer of the oral cavity - ‘The causal relationship of the smoking of pipes to the
development of cancer of the lip appears to be established. Although there are
suggestions of relationships between cancer of other speciﬁc sites of the oral cavity
and the several forms of tobacco use, their causal implications cannot at present be
stated.’
publication is observed, for example between 1919 and 1920 and 1961 and
1962. For oral cancer, the variance of P increases throughout the time pe-
riod, reﬂecting the increased uncertainty associated with classifying studies
suggesting that tobacco is harmful, having taken a prior position that it is
not.
For lung cancer the story is similar, although it is compressed into a
shorter time-span and the weight of evidence suggesting that tobacco use is
harmful exceeds that for oral cancer from 1950 onwards. The ﬁrst change in
the lung cancer series occurs in 1939, with the publication of Müller (1939).
Sporadic studies are observed during the 1940s, with the main body of evi-
dence accumulating during the 1950s. In 1949, beliefs regarding P are identi-
cal for lung and oral cancer, reﬂected in the identical values for E[P1949] and
var(P1949). Thereafter, the lung cancer series has a higher mean and lower
variance than the oral cancer series. var(Pt) for lung cancer rises at ﬁrst but






























Laryngeal cancer: Bayes var*100  Oesophageal cancer: Bayes var*100 
Figure 4: Laryngeal and oesophageal cancer series for Surgeon General’s
Advisory Committee: mean and 100*variance of distribution of beliefs re-
garding p, 1919 - 1963.
Advisory Committee’s assessment of the evidence for each site:
Laryngeal cancer - ‘Evaluation of the evidence leads to the judgment that cigarette
smoking is a signiﬁcant factor in the causation of laryngeal cancer in the male.’
Oesophageal cancer - ‘The evidence on the tobacco-esophagealrelationship supports
the belief that an association exists. However, the data are not adequate to decide
whether the relationship is causal.’
falls from 1955 onwards, after the sample information becomes strong enough
to reduce the uncertainty introduced by classifying studies concluding that
tobacco use is harmful.
Figures 4 and 5 show that, for laryngeal, oesophageal and urinary bladder
cancer, the story is similar. However, the increments for these series are
compressed into an even smaller time frame and the weight evidence by
1963 is less strong. Figure 5 shows how the mean and variance for stomach
cancer are virtually invariant over time: four studies reported, in 1946, 1957,
1960 and 1961, and all were classiﬁed by the Advisory Committee as showing
that tobacco use was not harmful, which is consistent with prior beliefs.
4.2 Results for the T.I.R.C. and the Surgeon General’s Ad-
visory Committee compared
Results comparing E[P1963] and var(P1963) based on the evidence collected
by the U.S. Surgeon General’s Advisory Committee and that collected by
the T.I.R.C. are shown in table 2. For lung cancer, the means and variances






























Urinary bladder cancer: Bayes var*100  Stomach cancer: Bayes var*100 
Figure 5: Urinary bladder and stomach cancer series for Surgeon Gen-
eral’s Advisory Committee: mean and 100*variance of distribution of beliefs
regarding p, 1919 - 1963.
Advisory Committee’s assessment of the evidence for each site:
Urinary bladder cancer - ‘Available data suggest an association between cigarette
smoking and urinary bladder in the male but are not suﬃcient to support a judg-
ment on the causal signiﬁcance of this association.’
Stomach cancer - ‘No relationship has been established between tobacco use and
stomach cancer.’
for each organisation are almost identical in 1963. The T.I.R.C.’s slightly
lower mean and higher variance are accounted for by the fact that it had
reviewed slightly fewer studies in the Catalog and Current Digest than the
Advisory Committee and that one of the studies reviewed by the T.I.R.C.
was classiﬁed as ‘B, unclear’ in the Catalog (Watson, 1950) and therefore
as ‘tobacco not harmful’ in the Bayesian model. For oral cancer, the lower
mean and variance for the T.I.R.C. in 1963 are accounted for mainly by
the low number of studies published prior to August 1955 that had been
summarised in the Catalog. For the other four cancer sites, the T.I.R.C.’s
mean and variance are higher than those of the Advisory Committee.15
15For laryngeal cancer this is because the Surgeon General’s Advisory Committee clas-
siﬁed two studies (Schrek et al. (1950) and Valko (1952)) as being unclear in their conclu-
sions. The T.I.R.C. classiﬁed Schrek et al. as ‘C, tobacco harmful’ in the Catalog and did
not review Valko. For oesophageal cancer, the T.I.R.C. series is higher because its series
comprises more studies, namely Stocks (1957), Pernu (1960), Shanta and Krishnamurthi
(1963) and Levin (1963). For urinary bladder and stomach cancer, the T.I.R.C.’s mean
and variance are higher because it reviewed and classiﬁed as harmful one more study than
the Advisory Committee (Levin, 1963 and Pernu, 1960 respectively).
19Surgeon General’s
Advisory Committee T.I.R.C.
Cancer site Et[P] vart(P) E[Pt] var(Pt)
Starting values for all sites (t = 1919) 0.0375 0.0009 0.0375 0.0009
Values of series (t = 1963)
Lung 0.4966 0.0033 0.4619 0.0034
Oral cavity 0.3272 0.0038 0.2619 0.0037
Larynx 0.1916 0.0031 0.2320 0.0035
Oesophagus 0.1429 0.0026 0.1645 0.0030
Urinary bladder 0.1260 0.0025 0.1457 0.0027
Stomach 0.0340 0.0007 0.0570 0.0012
Table 2: U.S. Surgeon General’s Advisory Committee and T.I.R.C.: com-
parison of means and variances for the distribution of beliefs regarding p for
each cancer site in 1963.
Figures 6 to 11 compare the evolution of the series for the T.I.R.C. and
the U.S. Public Health Service and related groups between 1950 and 1963.
The T.I.R.C. series are plotted according to the year at which the studies
appeared in the Catalog (1955 and for lung, oral and laryngeal cancer only)
and the Current Digest (yearly from 1956 onwards and for all cancer sites).
The series for the U.S. Public Health Service and related groups are plotted
according to the date at which the evidence was reported and assessed in a
public statement. For lung cancer, this corresponds to the years 1957 (Study
Group on Smoking and Health, 1957 and Burney, 1958), 1959 (statement of
Burney (1959)) and 1964 (‘Smoking and Health’). The other ﬁve sites do
not appear to have been comprehensively reviewed by the service until 1964,
which accounts for the single increments in the Public Health Service series
in Figures 7 to 11.
For the lung cancer series, Figure 6 also compares the assessments of
the evidence regarding smoking and lung cancer made by the T.I.R.C. in its
annual reports of the Scientiﬁc Director and the U.S. Public Health Service
and related groups, in 1957, 1959 and 1964. A plot of the Beta distributions
for the U.S. Public Health Service and related groups at the prior stage,
1957, 1959 and 1963 is shown in ﬁgure 12.
Figure 6 shows how, for lung cancer, the information contained within the
T.I.R.C.’s Catalog of 1955 - every study but one reviewed in this document
was given a ‘C, tobacco harmful’ classiﬁcation - caused E[P1955] to jump
(from its prior value of 0.0375 to 0.2842) and the variance to rise (0.0009 to
0.0037). Thereafter, the mean increases steadily, reﬂecting the fact that the
T.I.R.C. was swift to make summaries of studies available in the Current
Digest. The U.S. Public Health Service series changes ﬁrst in 1957, with
the publication of the Study Group’s report on smoking and health. It can
be seen that the study group’s report included more studies classiﬁed as
20‘tobacco harmful’, since the 1957 mean of this series is higher than that of
the T.I.R.C.. The series increments again in 1959, when the Surgeon General
added an additional six studies to the evidence base, and, ﬁnally, again in
1963, when twelve further studies were added by the Advisory Committee’s
report.
The quotes in Figure 6 demonstrate the striking diﬀerence in the inter-
pretation of the evidence available to the organisations. The Study Group
and the Surgeon General were suggesting a causal relationship for excessive
smoking and lung cancer in 1957 (phrases used include ‘beyond reasonable
doubt’ and ‘the weight of evidence is increasingly pointing in one direction’).
In 1959, the Surgeon General stated that the weight of evidence indicated
that smoking (rather than excessive smoking) was the ‘principal factor’ in
the increased incidence of lung cancer. By 1964 the relationship was deﬁned
as being unequivocally ‘causal’. These conclusions are not at odds with the
U.S. Public Health Service and related groups’ series plotted in Figure 6,
although it must be stressed the statements reﬂected an assessment of all of
the evidence available to these organisations, not solely the epidemiological
evidence which provides the input to our model. The T.I.R.C.’s statements
contrast sharply with the statements of the Public Health Service and related
groups as well as the series from the T.I.R.C.’s own model. The Scientiﬁc Di-
rector’s 1964 statement - that evidence suggesting that cigarettes exercise a
direct, carcinogenic eﬀect on man had not been forthcoming - is of particular
note. The possible reasons for this are addressed in the discussion.16
Finally, we note the T.I.R.C. series for the other ﬁve cancer sites in
Figures 7 to 11. We did not ﬁnd any detailed review or discussion of the
evidence relating to these cancer sites in the annual reports of the T.I.R.C.’s
Scientiﬁc Director for the period in question.
16A more detailed coverage of the annual reports of the T.I.R.C.’s Scientiﬁc Director
are presented, year by year between 1956 and 1964/5, in Forster et al. (2006).






























U.S. P.H.S. Bayes var*100  T.I.R.C. Bayes var*100 
Figure 6: Lung cancer series for U.S. Public Health Service and related
groups (U.S. P.H.S.) and T.I.R.C. compared: mean and 100*variance of
distribution of beliefs regarding p, 1950 - 1963. Assessments of the evidence:
1957
Surgeon General’s Study Group: ‘[t]he sum total of scientiﬁc evidence establishes
beyond reasonable doubt that cigarette smoking is a causative factor in the rapidly
increasing incidence of human epidermoid cancer of the lung’;
Surgeon General Burney: ‘the weight of evidence is increasingly pointing in one
direction: that excessive smoking is one of the causative factors in lung cancer.’
T.I.R.C.’s Annual Report of the Scientiﬁc Director: ‘such data would provide
clear evidence of the fact that the outward and visible habit of heavy smoking is a
reﬂection of such a wide and varied gamut of internal disturbances and unbalances
that its possible speciﬁc, causative value, becomes reduced almost to an absurdity.’
1959
Surgeon General Burney: ‘the weight of evidence at present implicates smoking as
the principal factor in the increased incidence of lung cancer ...cigarette smoking
particularly is associated with an increased chance of developing lung cancer.’
T.I.R.C.’s Annual Report of the Scientiﬁc Director: ‘growing support for the
point of view that the statistical association claimed by various studies has an
explanation or explanations that may still not be apparent from our present
knowledge.’
1964
Surgeon General’s Advisory Committee: ‘Cigarette smoking is causally related to
lung cancer in men; the magnitude of the eﬀect of cigarette smoking far outweighs
all other factors. The data for women, though less extensive, point in the same
direction.’
T.I.R.C.’s Annual Report of the Scientiﬁc Director: ‘over the years, however,
evidence to support the thesis that cigarettes exercise a direct carcinogenic eﬀect
on man has not been forthcoming.’






























U.S. P.H.S.  Bayes var*100  T.I.R.C. Bayes var*100 
Figure 7: Oral cancer series for Surgeon General’s Advisory Committee
and T.I.R.C. compared: mean and 100*variance of distribution of beliefs
regarding p, 1950 - 1963.






























U.S. P.H.S.  Bayes var*100  T.I.R.C. Bayes var*100 
Figure 8: Laryngeal cancer series for Surgeon General’s Advisory Commit-
tee and T.I.R.C. compared: mean and 100*variance of distribution of beliefs
regarding p, 1950 - 1963.






























U.S. P.H.S.  Bayes var*100  T.I.R.C. Bayes var*100 
Figure 9: Oesophageal cancer series for Surgeon General’s Advisory Com-
mittee and T.I.R.C. compared: mean and 100*variance of distribution of
beliefs regarding p, 1950 - 1963.






























U.S. P.H.S.  Bayes var*100  T.I.R.C. Bayes var*100 
Figure 10: Urinary bladder cancer series for Surgeon General’s Advisory
Committee and T.I.R.C. compared: mean and 100*variance of distribution
of beliefs regarding p, 1950 - 1963.






























U.S. P.H.S.  Bayes var*100  T.I.R.C. Bayes var*100 
Figure 11: Stomach cancer series for Surgeon General’s Advisory Commit-
tee and T.I.R.C. compared: mean and 100*variance of distribution of beliefs
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Figure 12: Evolution of Beta probability density function for beliefs re-
garding p for lung cancer, U.S. Public Health Service and related groups,
prior, 1957, 1959 and 1963.
255 Discussion
Viewed in terms of the ranking presented in table 1, the results of the
Bayesian model for the Surgeon General’s Advisory Committee are not at
odds with the overall assessments of the evidence made by it. Furthermore,
for lung cancer, the results plotted in ﬁgure 6 for the Study Group, Surgeon
General and Advisory Committee are reasonably consistent with the way in
which they assessed the accumulating body of evidence between 1957 and
1963.
What are radically diﬀerent are the assessments of the evidence in the
annual reports of the T.I.R.C.’s Scientiﬁc Director, when viewed in the light
of the output from the T.I.R.C. models. Firstly, for all sites other than lung
cancer, the reports failed to make any signiﬁcant reference to the evidence
base that was within the T.I.R.C.’s possession. Secondly, for lung cancer,
the diﬀerences in the assessment of the evidence are especially striking when
one considers that, by 1963, the T.I.R.C.’s series for lung cancer is virtu-
ally identical to that of the U.S. Public Health Service and related groups.
Although the annual reports of the T.I.R.C.’s Scientiﬁc Director made re-
peated references to the statistical associations between smoking and lung
cancer that had been reported within the epidemiological literature, they
were not, on their own or in combination with other evidence collected by
the T.I.R.C., suﬃcient to persuade the Scientiﬁc Director to declare the
relationship between tobacco use and lung cancer ‘causal’.
What factors could account for the failure of the model for lung cancer to
match the statements of the T.I.R.C.? The ﬁrst possibility is that, since the
epidemiological evidence was only one source of evidence used to assess the
causal relationship between tobacco use and lung cancer, the T.I.R.C. could
simply have attached far less weight to the epidemiological evidence when
assessing the overall body of evidence. This possibility is supported in the
annual reports of the Scientiﬁc Director, where frequent references are made
to the limitations of epidemiological evidence and statistical associations in
making judgments about causality. This is also the line of argument that
has been made by Talley et al. (2004) and Parascandola (2004) who use,
amongst others, the views of Fisher and Berkson as well as statements of
Dr. Lewis Robbins, Chief of Cancer Control Program, U.S. Public Health
Service, to support the point.17
The line of argument becomes confused, however, when one considers
that epidemiological evidence was, at times, used by the T.I.R.C. to make
judgments about causality. Forster et al. (2006) cite the example of the
Framingham study, a prospective epidemiological study, to which Little re-
ferred in his 1964/5 annual report: ‘cigarette smokers have no greater inci-
17For example, Talley et al. quote Robbins in 1962: ‘from the ﬁrst hint of a relation-
ship between smoking and cancer there was controversy, and that controversy continues’
(Robbins, 1962).
26dence of angina pectoris than non-smokers. Since this syndrome is regarded
as most often being a chronic manifestation of coronary artery sclerosis, this
ﬁnding suggests that smoking does not cause or accelerate such sclerosis
...at the present time therefore, the weight of evidence is against the con-
cept that either nicotine or smoking inﬂuences the atherosclerotic process.’
Forster et al. note that, prior to 1964, the T.I.R.C.’s Current Digest had
reported other evidence from the Framingham study suggesting that heavy
cigarette smokers experienced a threefold increase in the incidence of my-
ocardial infarction, but that this was not recorded by Little in any annual
report.
Secondly, even if the T.I.R.C. did give some weight to the epidemiological
evidence, it is clear that the prior beliefs of the T.I.R.C. and those of the U.S.
Public Health Service and related groups need not have been identical: the
T.I.R.C.’s prior beliefs could have diﬀered in terms of both their location
and spread. We believe that it is unrealistic to argue that, at the prior
stage, the T.I.R.C. could have expected fewer than around 3.75% of studies
incorrectly to reject a true null, given that the majority of hypothesis tests
in the studies appear to have applied hypothesis tests using 5% signiﬁcance
levels (one or two-tailed). However, it is quite possible that the variance of
the T.I.R.C.’s distribution of beliefs was smaller than that of the U.S. Public
Health Service and related groups.
Using techniques similar to those of Degroot and Schervisch (2002), we
can ask what strength of prior beliefs around E[P1919] could have led to
the T.I.R.C. drawing a conclusion that an association, but not a causal re-
lationship, existed between tobacco use and lung cancer, if its assessment
criteria were similar to those of the Surgeon General’s Advisory Commit-
tee. The Advisory Committee found the evidence within its possession
to have been strong enough to declare a causal relationship to exist be-
tween tobacco use and laryngeal cancer (E[P1963] = 0.1916,var(P1963) =
0.0031) but not oesophageal cancer (E[P1963] = 0.1429,var(P1963) = 0.0026).
Therefore, a simple approach is to ask how ‘tight’ prior beliefs for the
T.I.R.C. would have had to have been such that, for its beliefs in 1963,
0.1429 (‘association’ declared) < E[P1963] < 0.1916 (‘causality’ declared).
Given that, for lung cancer, the T.I.R.C. classiﬁed 32 studies as ‘tobacco
harmful’ and one as ‘tobacco neutral’, prior values at0 = 9.71 and bt0 =
249.16 would yield E[Pt0] = 0.0375 and E[P1963] = 0.1429. Prior values
at0 = 6.26 and bt0 = 160.38 would yield the same expected value for the
prior and E[P1963] = 0.1916. One way to evaluate the strength of these
alternative prior beliefs against tobacco being harmful is to consider the
probability that they allow for p to lie above a particular value. For exam-
ple, for the prior beliefs used in our model, there exists a probability of 0.025
that p lies above 0.114. For the more extreme prior just described (that
leading to E[P1963] = 0.1429) this probability falls to 0.0000029 and for the
less extreme prior it falls to 0.00012.
27Finally, this being the argument used by the likes of Glantz et al. (1996)
and in a number of legal cases, it could have been that, although privately,
there was a growing consensus within the tobacco industry that tobacco use
could cause cancer, the T.I.R.C. was reluctant to acknowledge this in public.
This line of argument ties in with the ‘false controversy’ story described in
the recent R.I.C.O. judgment and in the petitions lodged by the U.S. states
which led to the Master Settlement Agreement of 1998. For example, the
petition for the state of Iowa (State of Iowa v. R.J. Reynolds Tobacco Co.,
et al., 1996) cites an industry document sent in 1958 to the Vice President
of Research at Phillip Morris from a company researcher stating that ‘the
evidence ...is building up that heavy cigarette smoking contributes to lung
cancer either alone or in association with physical and physiological fac-
tors ...’ [par. 77c]. This is not too diﬀerent from the statements of 1957
made by the Study Group on Smoking and Health and the Surgeon General
that are quoted in ﬁgure 6 of this paper. And in 1963 the petition cites a
memorandum from consultants to Liggett stating: ‘[b]asically, we accept the
inference of a causal relationship between the chemical properties of ingested
tobacco smoke and the development of carcinoma, which is suggested in the
statistical association shown in the studies of Doll and Hill, Horn and Dorn
with some reservations and qualiﬁcations ...’ [par. 77h]. This is not too
diﬀerent from the assessment made by the U.S. Surgeon General’s Advisory
Committee that is also quoted in ﬁgure 6.
6 Conclusion
This paper has presented a Bayesian model of ‘health risk belief’ to track
the evolution of the ‘weight’ of epidemiological evidence concerning tobacco
harm that was in the possession of the T.I.R.C. and the U.S. Public Health
Service and related groups during the mid-twentieth century. Viewed ac-
cording to the date of publication of the articles reviewed by the Surgeon
General’s Advisory Committee, we have shown how the epidemiological evi-
dence, measured in a simple, qualitative manner, evolved between 1919 and
1963. We have also seen that the results of the models for the U.S. Public
Health Service and related groups are not in disagreement with their public
assessments of the evidence but that the T.I.R.C.’s model for lung cancer
is not consistent with the assessment of the evidence on lung cancer as ex-
pressed in the T.I.R.C.’s annual reports of its Scientiﬁc Director between
1956 and 1964/5. Although evidence relating to the other ﬁve cancer sites
had been reviewed by the T.I.R.C., we did not ﬁnd any detailed review or
discussion of it in the annual reports of the Scientiﬁc Director.
In considering the possible reasons for the failure of the T.I.R.C.’s model
for lung cancer to ﬁt well the statements expressed in the annual reports of
its Scientiﬁc Director, we note that C.C. Little was not completely averse
28to citing results from epidemiological studies since, on at least one occasion,
epidemiological evidence was used to support the case that tobacco was not
harmful. Whatever the wider argument about the ‘controversy’ regarding
tobacco harm during the 1950s and 1960s, we ﬁnd the credibility of the
T.I.R.C.’s ‘line’ on association and causation diminished signiﬁcantly by such
selective use of evidence.
In our discussion, we also considered the importance of the strength of
prior beliefs in aﬀecting the outputs of the model, as well as the possible con-
ﬂict that existed in the tobacco industry between judgments being made in
private and statements being made in public. The credibility of the ‘strength
of prior beliefs’ argument rests on the credibility of the T.I.R.C. possessing
‘tight’ prior beliefs which attach very low probabilities to observing a high
population proportion of studies concluding that tobacco is harmful. The
credibility of the ‘public versus private’ argument relies on the credibility
and persuasiveness of the views expressed ‘privately’ by tobacco industry
employees and consultants, considered alongside the evidence that was in
the possession of the T.I.R.C. and the views that the T.I.R.C.’s Scientiﬁc
Director was expressing in public.
29A Interpretation of p under the null and alternative
hypotheses
This section expands on the meaning of the population proportion of studies,
p, which conclude that tobacco use is harmful and about which beliefs are
modelled using Pt. We assume that the studies in the population test at least
one null hypothesis against a one- or two-tailed alternative hypothesis. The
focus of attention is on whether or not, considering the hypothesis tests and
other evidence from the study, the study is classiﬁed by the decision-maker
as showing:
• tobacco use is not harmful (which would occur if the study is classiﬁed
as showing tobacco to be beneﬁcial or neutral to health);
• tobacco use is harmful.
Let there be i ∈ 0,...,M, M ≤ ∞ studies in the population. The signiﬁ-
cance level of the hypothesis test for study i is set to be 100αi%, α ∈ (0,1),
and can vary across studies. We also note that the decision-maker’s classiﬁ-
cation of studies is based not solely on the result of hypothesis tests but also
on factors such as an assessment of the overall quality of the study’s design,
the competence of the study’s investigators and so on.
Consider the situation in which tobacco is not harmful. The proba-
bility that a hypothesis test carried out by study i incorrectly concludes
that tobacco use is harmful is equal to αi (one-tailed test) or αi/2 (two-
tailed test). Assuming that, when reviewing studies, the decision-maker
might not base its conclusion solely on the result of a single hypothesis test,
and/or that authors might use other information in addition to that pro-
vided by hypothesis tests to draw ﬁnal conclusions about tobacco harm,
deﬁne a separate random variable, Λ ∈ (0,1), to represent the distribution
of Pr(study incorrectly concludes that tobacco is harmful) within the pop-
ulation, where λ is an individual study’s realisation of Λ. p is therefore:




where θ is the probability density function for Λ.
If the null hypothesis is not true, then the probability that study i’s hy-
pothesis test correctly rejects the null is equal to the power of the hypothesis
test, βi. Again, the conclusions regarding tobacco harm reached by studies
within the population may not be based solely on the results of a single
hypothesis test, or might include other information available to the authors,
and hence we deﬁne the random variable Ω ∈ (0,1) to represent the dis-
tribution of Pr(study correctly conclude that tobacco use is harmful) in the
population. Let ω be an individual study’s realisation of Ω. This probability
30will be dependent upon the degree to which the disease is multi-causal in
nature (which will aﬀect the positioning of the sampling distribution of the
point estimate of eﬀect, such as the odds ratio or the relative risk, under the
alternative hypothesis) as well as the study’s sample size (which will aﬀect
the spread of this sampling distribution). In this scenario, p is the expected
value of Ω:




where ￿ is the probability density function for Ω.
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